US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors ...Middle East

PR Newswire - News
US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors
The liquid biopsy has been developed by Datar Cancer Genetics to help diagnose brain tumors where a conventional biopsy is not possible. A prospective, blinded study by a research team at the Imperial College, London showed very high accuracy in detecting malignant brain tumors. Datar...

Hence then, the article about us fda grants breakthrough designation for blood test to help diagnose inaccessible brain tumors was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors )

Apple Storegoogle play

Last updated :

Also on site :



Latest News
before 12 minute